Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Publikationen
Suchbegriffe: HYPOGLYCAEMIA, . Treffer: 86
2023
Heller, S; Battelino, T; Bailey, TS; Pieber, TR; Hovelmann, U; Plum-Morschel, L; Melgaard, AE; Aronson, R; DiMeglio, LA; Johansen, T; Danne, T
Integrated safety and efficacy analysis of dasiglucagon for the treatment of severe hypoglycaemia in individuals with type 1 diabetes
DIABETES OBES METAB. 2023;
Doi: 10.1111/dom.14987
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Rafferty, J; Eckstein, ML; Aziz, F; Bain, SC; Bergenstal, R; Sourij, H; Thomas, RL
Impact of severe hypoglycaemia requiring hospitalization on mortality in people with type 1 diabetes: A national retrospective observational cohort study.
Diabetes Obes Metab. 2023;
Doi: 10.1111/dom.15102
PubMed
FullText
FullText_MUG
2022
Boughton, CK; Hartnell, S; Thabit, H; Mubita, WM; Draxlbauer, K; Poettler, T; Wilinska, ME; Hood, KK; Mader, JK; Narendran, P; Leelarathna, L; Evans, ML; Hovorka, R
Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study
LANCET HEALTH LONGEV. 2022; 3(3): E135-E142.
Doi: 10.1016/S2666-7568(22)00005-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Divilly, P; Zaremba, N; Mahmoudi, Z; Søholm, U; Pollard, DJ; Broadley, M; Abbink, EJ; de, Galan, B; Pedersen-Bjergaard, U; Renard, E; Evans, M; Speight, J; Brennan, A; McCrimmon, RJ; Müllenborn, M; Heller, S; Seibold, A; Mader, JK; Amiel, SA; Pouwer, F; Choudhary, P, , Hypo-RESOLVE, Consortium
Hypo-METRICS: Hypoglycaemia-MEasurement, ThResholds and ImpaCtS-A multi-country clinical study to define the optimal threshold and duration of sensor-detected hypoglycaemia that impact the experience of hypoglycaemia, quality of life and health economic outcomes: The study protocol.
Diabet Med. 2022; 39(9):e14892
Doi: 10.1111/dme.14892
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Eyileten, C; Wicik, Z; Keshwani, D; Aziz, F; Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Prietl, B; Prüller, F; von, Lewinski, D; De, Rosa, S; Siller-Matula, JM; Postula, M; Sourij, H
Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.
Cardiovasc Diabetol. 2022; 21(1): 79
Doi: 10.1186/s12933-022-01517-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pieber, TR; Aronson, R; Christiansen, MP; Bode, B; Junaidi, K; Conoscenti, V
Efficacy, safety, tolerability, and noninferiority phase 3 study of glucagon as a ready-to-use room temperature liquid stable formulation versus a lyophilised formulation for the biochemical recovery and symptomatic relief of insulin-induced severe hypoglycaemia in adults with type 1 diabetes.
Diabetes Obes Metab. 2022; 24(7):1394-1397
Doi: 10.1111/dom.14699
Web of Science
PubMed
FullText
FullText_MUG
2021
Boughton, CK; Hartnell, S; Thabit, H; Poettler, T; Herzig, D; Wilinska, ME; Ashcroft, NL; Sibayan, J; Cohen, N; Calhoun, P; Bally, L; Mader, JK; Evans, M; Leelarathna, L; Hovorka, R
Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: A double-blind, multicentre, multinational, randomized, crossover study.
Diabetes Obes Metab. 2021; 23(6):1389-1396
Doi: 10.1111/dom.14355
Web of Science
PubMed
FullText
FullText_MUG
Diouri, O; Cigler, M; Vettoretti, M; Mader, JK; Choudhary, P; Renard, E, , HYPO-RESOLVE, Consortium
Hypoglycaemia detection and prediction techniques: A systematic review on the latest developments.
Diabetes Metab Res Rev. 2021; e3449
Doi: 10.1002/dmrr.3449
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Elbarbary, N; Moser, O; Al Yaarubi, S; Alsaffar, H; Al Shaikh, A; Ajjan, RA; Deeb, A
Use of continuous glucose monitoring trend arrows in the younger population with type 1 diabetes
DIABETES VASC DIS RE. 2021; 18(6): 14791641211062155
Doi: 10.1177/14791641211062155
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fabricius, TW; Verhulst, CEM; Kristensen, PL; Tack, CJ; McCrimmon, RJ; Heller, S; Evans, ML; Amiel, SA; Pieber, TR; de Galan, BE; Pedersen-Bjergaard, U; Hypo-RESOLVE consortium
Hyperinsulinaemic-hypoglycaemic glucose clamps in human research: a systematic review of the literature.
Diabetologia. 2021; 64(4):727-736
Doi: 10.1007/s00125-020-05361-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fuchs, J; Allen, JM; Boughton, CK; Wilinska, ME; Thankamony, A; de Beaufort, C; Campbell, F; Yong, J; Froehlich-Reiterer, E; Mader, JK; Hofer, SE; Kapellen, TM; Rami-Merhar, B; Tauschmann, M; Hood, K; Kimbell, B; Lawton, J; Roze, S; Sibayan, J; Cohen, N; Hovorka, R; KidsAP Consortium
Assessing the efficacy, safety and utility of closed-loop insulin delivery compared with sensor-augmented pump therapy in very young children with type 1 diabetes (KidsAP02 study): an open-label, multicentre, multinational, randomised cross-over study protocol.
BMJ Open. 2021; 11(2): e042790-e042790.
Doi: 10.1136/bmjopen-2020-042790
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Garden, GL; Frier, BM; Hine, JL; Hutchison, EJ; Mitchell, SJ; Shaw, KM; Heller, SR; Koehler, G; Hofmann, V; Gaffney, TP; Maher, D; Roberts, GA; Russell-Jones, DL
Blood glucose monitoring by insulin-treated pilots of commercial and private aircraft: An analysis of out-of-range values
DIABETES OBES METAB. 2021;
Doi: 10.1111/dom.14471
Web of Science
PubMed
FullText
FullText_MUG
Jasser-Nitsche, H; Bechtold-Dalla Pozza, S; Binder, E; Bollow, E; Heidtmann, B; Lee-Barkley, YH; Raile, K; de Sousa, G; Schramm, U; Holl, RW
Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes.
Acta Paediatr. 2021; 110(4):1353-1358
Doi: 10.1111/apa.15643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Simic, A; Schøndorff, PK; Stumpe, T; Heschel, M; Regittnig, W; Pöttler, T; Ninaus, D; Augustin, T; Groselj-Strele, A; Pieber, TR; Mader, JK, ;on behalf of the Hypo-RESOLVE, Consortium;AiDAPT, AP@home04, CLOuD, DAN05, DAN06, and, KidsAP, consortia;HYPO-RESOLVE, Consortium;KidsAP, Consortium
Survival assessment of the extended-wear insulin infusion set featuring lantern technology in adults with type 1 diabetes by the glucose clamp technique.
Diabetes Obes Metab. 2021; 23(6):1402-1408
Doi: 10.1111/dom.14337
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2020
Aberer, F; Pferschy, PN; Tripolt, NJ; Sourij, C; Obermayer, AM; Prüller, F; Novak, E; Reitbauer, P; Kojzar, H; Prietl, B; Kofler, S; Brunner, M; Svehlikova, E; Stojakovic, T; Scharnagl, H; Oulhaj, A; Aziz, F; Riedl, R; Sourij, H
Hypoglycaemia leads to a delayed increase in platelet and coagulation activation markers in people with type 2 diabetes treated with metformin only: Results from a stepwise hypoglycaemic clamp study.
Diabetes Obes Metab. 2020; 22(2):212-221
Doi: 10.1111/dom.13889
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
de Galan, BE; McCrimmon, RJ; Ibberson, M; Heller, SR; Choudhary, P; Pouwer, F; Speight, J; Carlton, J; Pieber, TR; Rosilio, M; Tack, CJ; Müllenborn, M; Hypo-RESOLVE Consortium
Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo-RESOLVE) project.
Diabet Med. 2020;
Doi: 10.1111/dme.14240
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Egan, AM; Bogdanet, D; Griffin, TP; Kgosidialwa, O; Cervar-Zivkovic, M; Dempsey, E; Allotey, J; Alvarado, F; Clarson, C; Cooray, SD; de Valk, HW; Galjaard, S; Loeken, MR; Maresh, MJA; Napoli, A; O'Shea, PM; Wender-Ozegowska, E; van Poppel, MNM; Thangaratinam, S; Crowther, C; Biesty, LM; Devane, D; Dunne, FP; INSPIRED research group
A core outcome set for studies of gestational diabetes mellitus prevention and treatment.
Diabetologia. 2020; 63(6):1120-1127
Doi: 10.1007/s00125-020-05123-6
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Evans, M; Moes, RGJ; Pedersen, KS; Gundgaard, J; Pieber, TR
Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U300 in the Netherlands: Evidence From a Randomised Controlled Trial.
Adv Ther. 2020; 37(5):2413-2426
Doi: 10.1007/s12325-020-01332-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heller, S; Lingvay, I; Marso, SP; Philis-Tsimikas, A; Pieber, TR; Poulter, NR; Pratley, RE; Hachmann-Nielsen, E; Kvist, K; Lange, M; Moses, AC; Andresen, MT; Buse, JB; DEVOTE Study Group
Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE.
Diabetes Obes Metab. 2020;
Doi: 10.1111/dom.14049
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Heller, S; Lingvay, I; Marso, SP; Philis-Tsimikas, A; Pieber, TR; Poulter, NR; Pratley, RE; Hachmann-Nielsen, E; Kvist, K; Lange, M; Moses, AC; Trock Andresen, M; Buse, JB; DEVOTE Study Group
Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE.
Diabetes Obes Metab. 2020; 22(12):2248-2256
Doi: 10.1111/dom.14208
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Libiseller, A; Kopanz, J; Lichtenegger, KM; Mader, JK; Truskaller, T; Lackner, B; Aberer, F; Pandis, M; Reinisch-Gratzer, J; Ambrosch, GC; Sinner, F; Pieber, TR; Donsa, K
Study protocol for assessing the user acceptance, safety and efficacy of a tablet-based workflow and decision support system with incorporated basal insulin algorithm for glycaemic management in participants with type 2 diabetes receiving home health care: A single-centre, open-label, uncontrolled proof-of-concept study.
Contemp Clin Trials Commun. 2020; 19(10):100620-100620
Doi: 10.1016/j.conctc.2020.100620
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van, den, Boom, L; Gillard, P; Nørgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; de, Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Diabetologia. 2020; 63(12):2501-2520
Doi: 10.1007/s00125-020-05263-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Riddell, MC; Eckstein, ML; Adolfsson, P; Rabasa-Lhoret, R; van den Boom, L; Gillard, P; Nørgaard, K; Oliver, NS; Zaharieva, DP; Battelino, T; de Beaufort, C; Bergenstal, RM; Buckingham, B; Cengiz, E; Deeb, A; Heise, T; Heller, S; Kowalski, AJ; Leelarathna, L; Mathieu, C; Stettler, C; Tauschmann, M; Thabit, H; Wilmot, EG; Sourij, H; Smart, CE; Jacobs, PG; Bracken, RM; Mader, JK
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).
Pediatr Diabetes. 2020; 21(8):1375-1393
Doi: 10.1111/pedi.13105
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Ziko, H; Elsayed, H; Hochfellner, DA; Pöttler, T; Mueller, A; Eckstein, ML; Sourij, H; Mader, JK, , Hypo-RESOLVE, Consortium
People with type 1 diabetes and impaired awareness of hypoglycaemia have a delayed reaction to performing a glucose scan during hypoglycaemia: a prospective observational study.
Diabet Med. 2020; 37(12):2153-2159
Doi: 10.1111/dme.14362
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Philis-Tsimikas, A; Klonoff, DC; Khunti, K; Bajaj, HS; Leiter, LA; Hansen, MV; Troelsen, LN; Ladelund, S; Heller, S; Pieber, TR; CONCLUDE Study Group
Risk of hypoglycaemia with insulin degludec versus insulin glargine U300 in insulin-treated patients with type 2 diabetes: the randomised, head-to-head CONCLUDE trial.
Diabetologia. 2020;
Doi: 10.1007/s00125-019-05080-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pieber, TR; Bardtrum, L; Isendahl, J; Wagner, L; Nishimura, R
Commentary to "Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec" by Kawaguchi et al. Diabetes Therapy 2019.
Diabetes Ther. 2020; 11(2): 561-567.
Doi: 10.1007/s13300-019-00755-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Scarpellini, E; Arts, J; Karamanolis, G; Laurenius, A; Siquini, W; Suzuki, H; Ukleja, A; Van Beek, A; Vanuytsel, T; Bor, S; Ceppa, E; Di Lorenzo, C; Emous, M; Hammer, H; Hellström, P; Laville, M; Lundell, L; Masclee, A; Ritz, P; Tack, J
International consensus on the diagnosis and management of dumping syndrome.
Nat Rev Endocrinol. 2020; 16(8):448-466
Doi: 10.1038/s41574-020-0357-5
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Semlitsch, T; Engler, J; Siebenhofer, A; Jeitler, K; Berghold, A; Horvath, K
(Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2020; 11: CD005613-CD005613.
Doi: 10.1002/14651858.CD005613.pub4
Web of Science
PubMed
FullText
FullText_MUG
2019
Aberer, F; Lichtenegger, KM; Smajic, E; Donsa, K; Malle, O; Samonigg, J; Höll, B; Beck, P; Pieber, TR; Plank, J; Mader, JK
GlucoTab-guided insulin therapy using insulin glargine U300 enables glycaemic control with low risk of hypoglycaemia in hospitalized patients with type 2 diabetes.
Diabetes Obes Metab. 2019; 21(3):584-591
Doi: 10.1111/dom.13559
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Brown-Frandsen, K; Emerson, SS; McGuire, DK; Pieber, TR; Poulter, NR; Pratley, RE; Zinman, B; Ranthe, MF; Grøn, R; Lange, M; Moses, AC; Örsy, P; Buse, JB; DEVOTE Study Group
Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10).
Diabetes Obes Metab. 2019; 21(6):1437-1444
Doi: 10.1111/dom.13677
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Eckstein, ML; McCarthy, O; Deere, R; Pitt, J; Williams, DM; Hayes, J; Sourij, H; Bain, SC; Bracken, RM
Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial.
Diabetes Obes Metab. 2019; 21(11): 2505-2512.
Doi: 10.1111/dom.13835
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Eckstein, ML; Mueller, A; Birnbaumer, P; Aberer, F; Koehler, G; Sourij, C; Kojzar, H; Holler, P; Simi, H; Pferschy, P; Dietz, P; Bracken, RM; Hofmann, P; Sourij, H
Impact of physical exercise on sensor performance of the FreeStyle Libre intermittently viewed continuous glucose monitoring system in people with Type 1 diabetes: a randomized crossover trial.
Diabet Med. 2019; 36(5):606-611
Doi: 10.1111/dme.13909
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Eckstein, ML; Mueller, A; Birnbaumer, P; Aberer, F; Koehler, G; Sourij, C; Kojzar, H; Holler, P; Simi, H; Pferschy, P; Dietz, P; Bracken, RM; Hofmann, P; Sourij, H
Reduction in insulin degludec dosing for multiple exercise sessions improves time spent in euglycaemia in people with type 1 diabetes: A randomized crossover trial.
Diabetes Obes Metab. 2019; 21(2):349-356
Doi: 10.1111/dom.13534
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Moser, O; Pandis, M; Aberer, F; Kojzar, H; Hochfellner, D; Elsayed, H; Motschnig, M; Augustin, T; Kreuzer, P; Pieber, TR; Sourij, H; Mader, JK
A head-to-head comparison of personal and professional continuous glucose monitoring systems in people with type 1 diabetes: Hypoglycaemia remains the weak spot.
Diabetes Obes Metab. 2019; 21(4):1043-1048
Doi: 10.1111/dom.13598
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pollock, RF; Heller, S; Pieber, TR; Woo, V; Gundgaard, J; Hallén, N; Luckevich, M; Tutkunkardas, D; Zinman, B; DEVOTE Study Group
Short-term cost-utility of degludec versus glargine U100 for patients with type 2 diabetes at high risk of hypoglycaemia and cardiovascular events: A Canadian setting (DEVOTE 9).
Diabetes Obes Metab. 2019; 21(7):1706-1714
Doi: 10.1111/dom.13730
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pratley, RE; Emerson, SS; Franek, E; Gilbert, MP; Marso, SP; McGuire, DK; Pieber, TR; Zinman, B; Hansen, CT; Hansen, MV; Mark, T; Moses, AC; Buse, JB; DEVOTE Study Group
Cardiovascular safety and lower severe hypoglycaemia of insulin degludec versus insulin glargine U100 in patients with type 2 diabetes aged 65 years or older: Results from DEVOTE (DEVOTE 7).
Diabetes Obes Metab. 2019; 21(7):1625-1633
Doi: 10.1111/dom.13699
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Rose, L; Kadowaki, T; Pieber, TR; Buchholtz, K; Ekelund, M; Gorst-Rasmussen, A; Philis-Tsimikas, A
Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials.
Diabetes Ther. 2019; 10(3):1029-1041
Doi: 10.1007/s13300-019-0608-4
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Schütz-Fuhrmann, I; Stadler, M; Zlamal-Fortunat, S; Rami-Merhar, B; Fröhlich-Reiterer, E; Hofer, SE; Mader, J; Resl, M; Bischof, M; Kautzky-Willer, A; Weitgasser, R
[Insulin pump therapy in children, adolescents and adults, guidelines (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):47-53
Doi: 10.1007/s00508-019-1485-6
Web of Science
PubMed
FullText
FullText_MUG
2018
Fullerton, B; Siebenhofer, A; Jeitler, K; Horvath, K; Semlitsch, T; Berghold, A; Gerlach, FM
Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus.
Cochrane Database Syst Rev. 2018; 12:CD013228-CD013228
Doi: 10.1002/14651858.CD013228
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Haluzík, M; Fulcher, G; Pieber, TR; Bardtrum, L; Tutkunkardas, D; Rodbard, HW
The co-formulation of insulin degludec and insulin aspart lowers fasting plasma glucose and rates of confirmed and nocturnal hypoglycaemia, independent of baseline glycated haemoglobin levels, disease duration or body mass index: A pooled meta-analysis of phase III studies in patients with type 2 diabetes.
Diabetes Obes Metab. 2018; 20(7):1585-1592
Doi: 10.1111/dom.13261
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Korsatko, S; Jensen, L; Brunner, M; Sach-Friedl, S; Tarp, MD; Holst, AG; Heller, SR; Pieber, TR
Effect of once-weekly semaglutide on the counterregulatory response to hypoglycaemia in people with type 2 diabetes: A randomized, placebo-controlled, double-blind, crossover trial.
Diabetes Obes Metab. 2018; 20(11):2565-2573
Doi: 10.1111/dom.13422
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Mader, JK; Lilly, LC; Aberer, F; Poettler, T; Johns, D; Trautmann, M; Warner, JL; Pieber, TR
Improved glycaemic control and treatment satisfaction with a simple wearable 3-day insulin delivery device among people with Type 2 diabetes.
Diabet Med. 2018; 35(10):1448-1456
Doi: 10.1111/dme.13708
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Pieber, TR; Marso, SP; McGuire, DK; Zinman, B; Poulter, NR; Emerson, SS; Pratley, RE; Woo, V; Heller, S; Lange, M; Brown-Frandsen, K; Moses, A; Barner Lekdorf, J; Lehmann, L; Kvist, K; Buse, JB; DEVOTE Study Group
DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality.
Diabetologia. 2018; 61(1):58-65
Doi: 10.1007/s00125-017-4422-0
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Ruan, Y; Bally, L; Thabit, H; Leelarathna, L; Hartnell, S; Tauschmann, M; Wilinska, ME; Evans, ML; Mader, JK; Kojzar, H; Dellweg, S; Benesch, C; Arnolds, S; Pieber, TR; Hovorka, R
Hypoglycaemia incidence and recovery during home use of hybrid closed-loop insulin delivery in adults with type 1 diabetes.
Diabetes Obes Metab. 2018; 20(8):2004-2008
Doi: 10.1111/dom.13304
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Welters, A; Meissner, T; Grulich-Henn, J; Fröhlich-Reiterer, E; Warncke, K; Mohnike, K; Blankenstein, O; Menzel, U; Datz, N; Bollow, E; Holl, RW
Characterization of diabetes following pancreatic surgery in patients with congenital hyperinsulinism.
Orphanet J Rare Dis. 2018; 13(1):230-230
Doi: 10.1186/s13023-018-0970-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Zinman, B; Marso, SP; Poulter, NR; Emerson, SS; Pieber, TR; Pratley, RE; Lange, M; Brown-Frandsen, K; Moses, A; Ocampo Francisco, AM; Barner Lekdorf, J; Kvist, K; Buse, JB; DEVOTE Study Group
Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2).
Diabetologia. 2018; 61(1):48-57
Doi: 10.1007/s00125-017-4423-z
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2017
Aberer, F; Hajnsek, M; Rumpler, M; Zenz, S; Baumann, PM; Elsayed, H; Puffing, A; Treiber, G; Pieber, TR; Sourij, H; Mader, JK
Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes.
Diabetes Obes Metab. 2017; 19(7):1051-1055
Doi: 10.1111/dom.12907
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bally, L; Thabit, H; Kojzar, H; Mader, JK; Qerimi-Hyseni, J; Hartnell, S; Tauschmann, M; Allen, JM; Wilinska, ME; Pieber, TR; Evans, ML; Hovorka, R
Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study.
Lancet Diabetes Endocrinol. 2017; 5(4):261-270
Doi: 10.1016/S2213-8587(17)30001-3
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
2016
Blevins, T; Pieber, TR; Colón Vega, G; Zhang, S; Bastyr, EJ; Chang, AM; IMAGINE 4 Investigators
Randomized double-blind clinical trial comparing basal insulin peglispro and insulin glargine, in combination with prandial insulin lispro, in patients with type 2 diabetes: IMAGINE 4.
Diabetes Obes Metab. 2016; 18(11):1072-1080
Doi: 10.1111/dom.12696
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fullerton, B; Siebenhofer, A; Jeitler, K; Horvath, K; Semlitsch, T; Berghold, A; Plank, J; Pieber, TR; Gerlach, FM
Short-acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus.
Cochrane Database Syst Rev. 2016; 29(6):CD012161-CD012161
Doi: 10.1002/14651858.CD012161
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Weitere 50 Treffer anzeigen